The FDA Academy is the Food and Drug Administration Philippines’ response to the challenge of providing educational platform for its employees, students, industries it regulate, and other stakeholders pursuant to RA 9711 or the FDA Act of 2009. With the tagline “Innovating Knowledge, Empowering People,” the FDA Academy is the key to educating the Filipinos on the role of regulatory enforcement in nation building. Read more...
In the implementation of the transitory provisions of the Implementing Rules and Regulations of Republic Act No. 9711 otherwise known as the FDA Act of 2009, the agency restructured its organization into the envisioned form of this Act through Department Personnel Order (DPO) No. 2012-5689. In its restructuring, there were several units created which were designed to respond to the dynamic needs of the agency’ internal and external stakeholders – among these was the FDA Academy. The FDA Academy (henceforth abbreviated as The Academy) was established to be a training center with a primary goal of bridging the competency and communication gap between the industry and the agency.
Stakeholders of the Academy
The Academy delivers seminars and trainings, hosts fora, and conducts internship programs to cater to the different needs of its identified stakeholders. For the industry – the Academy conducts accreditation and certification seminars, and hosts fora for FDA-Industry dialogues to promote regulatory compliance of its industry stakeholders. For Higher Education Institutions (HEI) – the Academy organizes student internship programs as a platform for exposing students of different academic backgrounds to the roles and responsibilities of FDA.
The Role of the Academy in FDA
The importance of the conduct of training, advocacy, and communication programs in relation to the implementation of health product regulation is enshrined in Republic Act 9711, otherwise known as the FDA Act of 2009. It is, in fact, highlighted as one of functions of the Policy and Planning Office (now Policy and Planning Service). When implemented well, such activities shall promote good submission practices, and are, hence, expected to yield a positive impact in the compliance of industry stakeholders to regulations. Additionally, these activities enhance transparency of FDA processes by providing a venue communicate rules, regulations, and procedures.